Drug Database
Back to search

Canada· CA-DIN-02519038

BLEXTEN

A bilastin product containing bilastine, registered in Canada by ARALEZ PHARMACEUTICALS CANADA INC. The same ATC class is registered in 11 of our 19 countries.

ATC R06AX29

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedBLEXTENATCR06AX29REGISTER NO.CA-DIN-02519038PACKS LISTED0CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about bilastineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bilastin is registered in 11 of 19 countries.

Countries holding a registration under ATC R06AX29 (bilastin), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose
Search bilastin products by name

Bilastin · ATC R06AX29

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bilastin costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.14 in France to $0.45 in Switzerland — a ×3.3 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Bilastin · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.45
  • FR France$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
BILASTINE
Manufacturer
ARALEZ PHARMACEUTICALS CANADA INC
Country
Canada (CA)
ATC code
R06AX29
ATC class
Bilastin
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bilastin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bilastin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Bilastin Hyperpoll, Bilastin Tiefenbacher
  • Belgium · Bellozal, Bilastine Ab
  • Bulgaria · Bilastine Stada, Биластин Мсн
  • Cyprus · Alivixa, Bilastine Delorbis
  • Czechia · Abisax, Bilastin Stada
  • Germany · Allegra Allergietabletten, Allegra Allergietabletten Kinder
  • Denmark · Bilastine Stada, Revitelle
  • Estonia · Bilastin, Bilastine Stada
  • Spain · Abisax, Abrilia
  • Finland · Bilastine Stada, Revitelle
  • France · Bilaska, Bilastine Arrow
  • United Kingdom (Northern Ireland) · Bilastine Medreich, Bilastine Milpharm
  • Greece · Bilargen, Bilastine Stada
  • Croatia · Actine, Nixar
  • Hungary · Bilastine Supremex, Bilastine Teva
  • Ireland · Bilastine Clonmel, Bilhista
  • Iceland · Bilaxten
  • Italy · Alyne, Ayrinal
  • Lithuania · Belargan, Bilastine Sandoz
  • Luxembourg · Bellozal, Bilastine Eurogenerics
  • Latvia · Bilastine Stada, Bilpexo
  • Malta · Alivixa, Bilastine Clonmel
  • Norway · Bilastine Stada, Zilas
  • Poland · Adablix, Allertec Effect
  • Portugal · Aelardis, Alostine
  • Romania · Bilastină Gemax Pharma, Bilastină Msn
  • Sweden · Bilacina, Bilastin Teva
  • Slovenia · Bilador, Bilastin Stada
  • Slovakia · Abisax, Bilastin Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/15d2daa1-d441-4a12-8ef8-03c9ff10af75
GET /v1/drugs/15d2daa1-d441-4a12-8ef8-03c9ff10af75?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02519038",
  "form": "TABLET (ORALLY DISINTEGRATING)",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "R06AX29",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "100831",
  "strengths": [
    "10 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "BILASTINE"
  ],
  "product_categorization": null
}
API referenceMCP serverPlans

See everything about bilastin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console